Tazemetostat and Venetoclax in Relapsed/Refractory Non-Hodgkin Lymphoma
Weill Medical College of Cornell University
Weill Medical College of Cornell University
University of Colorado, Denver
University of California, Davis
University of Washington
University of Washington
Roswell Park Cancer Institute
Thomas Jefferson University
Mayo Clinic
Massachusetts General Hospital
Thomas Jefferson University
Thomas Jefferson University
Wake Forest University Health Sciences
Thomas Jefferson University
Memorial Sloan Kettering Cancer Center
Stanford University
Fred Hutchinson Cancer Center
University of Wisconsin, Madison
Columbia University
Stanford University
Washington University School of Medicine
Loyola University
Centre Hospitalier Henri Duffaut - Avignon
University of Virginia
OHSU Knight Cancer Institute
Stanford University
University of Nebraska
University of Washington
Rutgers, The State University of New Jersey
University of Cologne
Fred Hutchinson Cancer Center
University of Washington
M.D. Anderson Cancer Center
Swiss Cancer Institute
University of California, San Diego
Rush University Medical Center
Weill Medical College of Cornell University
University of Liege
Northwestern University
Columbia University
Abramson Cancer Center at Penn Medicine
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
Burzynski Research Institute
Masonic Cancer Center, University of Minnesota
Barbara Ann Karmanos Cancer Institute
M.D. Anderson Cancer Center
University of Pennsylvania
NYU Langone Health
University of Texas Southwestern Medical Center
M.D. Anderson Cancer Center